title: Levodopa-induced breathing, cognitive and behavioral changes in Parkinson's disease.
authors.forename: Nicola
authors.initials: N
authors.lastname: Tambasco
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Belcastro
authors.forename: Antongiulio
authors.initials: A
authors.lastname: Gallina
authors.forename: Anna
authors.initials: A
authors.lastname: Castrioto
authors.forename: Paolo
authors.initials: P
authors.lastname: Calabresi
authors.forename: Aroldo
authors.initials: A
authors.lastname: Rossi
mesh_terms: D000368:Aged; D000978:Antiparkinson Agents / Q000009:adverse effects*; D002230:Carbidopa / Q000009:adverse effects*; D003072:Cognition Disorders / Q000139:chemically induced*; D004338:Drug Combinations; D006801:Humans; D007980:Levodopa / Q000009:adverse effects*; D008297:Male; D001523:Mental Disorders / Q000139:chemically induced*; D010300:Parkinson Disease / Q000188:drug therapy*; D012120:Respiration Disorders / Q000139:chemically induced*
chemical_list: D000978:Antiparkinson Agents; D004338:Drug Combinations; C009265:carbidopa, levodopa drug combination; D007980:Levodopa; D002230:Carbidopa